VEEV News

Veeva (VEEV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  1. Dow Jones Gains 1,083Points In 2 Days, Small Caps Surge; Sell These Growth Stocks Or Buy?  Investor's Business Daily
  2. Are the Global Fund Flow and US-China Tension Related?  Market Realist
  3. Dow reclaims 25K ahead of SpaceX-NASA delay…

Technically speaking, the S&P 500 has maintained key support (2,793) amid a respectable market whipsaw to start the worst six months seasonally, writes Michael Ashbaugh.

Veeva Systems (VEEV) announces a new application called MyVeeva to enable patient-centric clinical trials.

Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve patients' lives

Veeva Systems (NYSE: VEEV) today announced that the International Vaccine Institute (IVI), a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP), has implemented Veeva Vault Quality…

This company bringing innovative cloud data solutions to the health care sector is trading at a premium, but it isn't too late to buy.

Let's talk about the popular Veeva Systems Inc. (NYSE:VEEV). The company's shares received a lot of attention from a...

PLEASANTON, Calif.--(BUSINESS WIRE)-- #digitalengagement--Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve patients' lives

A new partner program helps CROs build studies faster with Veeva Vault EDC. Ten global CROs, including 5 of the top 7 largest CROs, have joined.

Okta indicated in its latest earnings report in early March that it had not experienced any business slowdown due to the pandemic.The company has strong revenue growth, strong free cash flow margin and easily meets the Rule of 40.The stock price appears to be…

Veeva Systems' (VEEV) fiscal first-quarter results are likely to reflect solid show by its segments and robust product portfolio.

Veeva Systems (VEEV) closed the most recent trading day at $197.37, moving -0.15% from the previous trading session.

The coronavirus pandemic has sent many stocks into freefall, and for good reason -- many companies have had to cut back their operations and lay off workers due to restrictions and lockdowns. Investors should consider buying these stocks that are poised for even bigger gains this year. Veeva Systems (NYSE: VEEV) stock is up 42% this year, largely thanks to its cloud business.

PLEASANTON, Calif.--(BUSINESS WIRE)-- #meddevice--Veeva Vault Product Surveillance is a new cloud application for medical device and diagnostics to simplify and standardize postmarket surveillance.

MyVeeva is a free application for sites with capabilities for virtual patient visits, patient adherence, ePRO, eConsent, eSource, and a patient portal

Veeva Systems' (VEEV) fiscal first-quarter results are likely to reflect solid show by its segments and robust product portfolio.

Three no-brainer tech stocks that are poised to benefit as companies accelerate plans for a cloud-based digital future are Veeva Systems (NYSE: VEEV), Okta (NASDAQ: OKTA), and Arista Networks Inc (NYSE: ANET). As cloud software started to become mainstream, Veeva CEO and co-founder Peter Gassner realized that there weren't quality software solutions for the highly regulated life sciences industry, so he started the company in 2007.

Amazon (NASDAQ: AMZN) and Microsoft (NASDAQ: MSFT) are often considered the top stocks in the cloud market. After all, Amazon Web Services (AWS) and Microsoft's Azure are the two largest cloud infrastructure platforms in the world, and both companies are leveraging their sprawling ecosystems to gain more customers. Amazon and Microsoft are still great investments, but investors shouldn't neglect other promising plays on the public cloud market, which could grow at a compound annual growth rate of 21% between 2018 and 2022, according to Forrester Research.

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down…

Let's talk about the popular Veeva Systems Inc. (NYSE:VEEV). The company's shares received a lot of attention from a...

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarte…

Veeva Systems (VEEV) closed at $197.73 in the latest trading session, marking a -1.35% move from the prior day.

Veeva Vault Site Connect automates the flow of information between sponsors and clinical research sites during clinical trials.

Dynatrace recently reported strong results for Q1 operations.Despite the impact of the virus on the economy it was able to show growth reacceleration-a rare achievement indeed for this time.The company, in its presentation, projected lots of tailwinds and a d…

Alvotech has adopted Veeva Vault Training for more effective role-based training within Europe.

BARCELONA, Spain--(BUSINESS WIRE)--Veeva announces new application to simplify global postmarket surveillance in medical device and diagnostics.

Veeva (VEEV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Veeva Systems (VEEV) closed at $197.73 in the latest trading session, marking a -1.35% move from the prior day.

Crossix, the industry leader in patient data, privacy, and analytics, announced today that it has joined the Network Advertising Initiative (NAI).

EIDD-2801 wasn't designed to fight the novel coronavirus, but its chemistry might make it an ideal weapon in this pandemic and the next

Veeva Systems (NYSE: VEEV) today announced that the International Vaccine Institute (IVI), a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP), has implemented Veeva Vault QualityDocs to improve control and real time visibility of standard operating procedures (SOPs) for audits and inspections. The move from paper-based processes to Vault QualityDocs will better enable IVI to meet compliance and GxP requirements of major drug administrations.

PLEASANTON, Calif.--(BUSINESS WIRE)-- #clinicaltrial--MyVeeva is a free application for sites with capabilities for virtual patient visits, patient adherence, ePRO, eConsent, eSource, and a patient portal

Great investments find ways to create quality that sometimes can't be measured by numbers alone Continue reading...

Project $1M delivered a strong April result, up nearly 15% for the month vs 13% for the S&P 500.While the S&P 500 may continue to decline, I believe the Project $1M portfolio has already found its 'bear market low' in March.Amazon, Facebook and ServiceNow wer…

Veeva Systems (NYSE: VEEV) today announced that the International Vaccine Institute (IVI), a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP), has implemented Veeva Vault Quality…

EIDD-2801 wasn't designed to fight the novel coronavirus, but its chemistry might make it an ideal weapon in this pandemic and the next

PLEASANTON, Calif.--(BUSINESS WIRE)-- #drugsafety--Veeva Vault Signal is the industry’s first solution that seamlessly manages signals from identification through risk evaluation and mitigation.

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the m…

Veeva Systems (NYSE: VEEV) and Salesforce (NYSE: CRM) are two closely linked companies in the cloud-based CRM (customer relationship management) space. Salesforce, which was founded 21 years ago, is the world's largest CRM company. In 2007, Peter Gassner, Salesforce's former senior VP of technology, co-founded Veeva to develop dedicated CRM solutions for pharmaceutical and life science companies.